SPOTLIGHT: Who are pharma's true VIPs?

You mean you don't know? Helpfully, a trade magazine has ranked them for you: the 40 most influential people in pharma. And they're not always the people you'd expect. Report

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.